Elscint veteran Sohval joins SmartLight

Article

Former Elscint executive Robert Sohval has joined SmartLight,an Israeli technology firm that has developed a computer-controlledlight box designed to automatically mask glare from light usedto illuminate x-ray films (SCAN 1/31/96). Sohval has been

Former Elscint executive Robert Sohval has joined SmartLight,an Israeli technology firm that has developed a computer-controlledlight box designed to automatically mask glare from light usedto illuminate x-ray films (SCAN 1/31/96). Sohval has been namedpresident and CEO of SmartLight's U.S. subsidiary, based in Hackensack,NJ.

Sohval left Elscint in 1994 for TransScan Medical, a development-stagecompany working on breast-imaging technology using electricalimpedance rather than x-rays. At SmartLight, one of Sohval's firstduties is to build a sales and marketing organization to sellthe company's SmartLight 2000 Plus and SmartLight 4000 Plus systems.

SmartLight has placed the systems at beta sites and expectsto begin commercial shipments in the fourth quarter of this year,Sohval said.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.